Detalhe da pesquisa
1.
Ubiquitous expression of HBsAg from integrated HBV DNA in patients with low viral load.
J Hepatol;
75(4): 840-847, 2021 10.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34004216
2.
Transition to HBeAg-negative chronic hepatitis B virus infection is associated with reduced cccDNA transcriptional activity.
J Hepatol;
74(4): 794-800, 2021 04.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33188905
3.
Hepatitis B Virus Does Not Interfere With Innate Immune Responses in the Human Liver.
Gastroenterology;
154(6): 1778-1790, 2018 05.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29408639
4.
New insights into HDV-induced innate immunity: MDA5 senses HDV replication.
J Hepatol;
69(1): 5-7, 2018 07.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29654818
5.
Studying Hepatitis Virus-Host Interactions in Patient Liver Biopsies.
Viruses;
14(11)2022 11 10.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36366588
6.
Integrative proteogenomic characterization of hepatocellular carcinoma across etiologies and stages.
Nat Commun;
13(1): 2436, 2022 05 04.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35508466
7.
Supervised learning based on tumor imaging and biopsy transcriptomics predicts response of hepatocellular carcinoma to transarterial chemoembolization.
Cell Rep Med;
2(11): 100444, 2021 11 16.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34841291
8.
Interferon lambda 4 impairs hepatitis C viral antigen presentation and attenuates T cell responses.
Nat Commun;
12(1): 4882, 2021 08 12.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34385466
9.
Interferon lambda 4 can directly activate human CD19+ B cells and CD8+ T cells.
Life Sci Alliance;
4(1)2021 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33158978
10.
Modulators of innate immunity as novel therapeutics for treatment of chronic hepatitis B.
Curr Opin Virol;
30: 9-17, 2018 06.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29444493
11.
Transcriptional response to hepatitis C virus infection and interferon-alpha treatment in the human liver.
EMBO Mol Med;
9(6): 816-834, 2017 06.
Artigo
em Inglês
| MEDLINE
| ID: mdl-28360091